Dendritic Cell Activation via Antigen Presentation Pathway (N/A)

Dendritic cell activation via the antigen presentation pathway is a critical process by which dendritic cells (DCs) capture, process, and present antigens to T lymphocytes, initiating adaptive immune responses. This process involves antigen uptake, processing into peptides, loading onto MHC molecules (MHC I and MHC II), and presentation to T cells, along with co-stimulatory signals. Dysregulation of this pathway can lead to immunodeficiency, autoimmunity, or chronic inflammation. Therapeutic interventions targeting this pathway aim to modulate DC function to enhance anti-tumor immunity, control infections, or restore immune tolerance in autoimmune diseases.

Other names

DC ActivationAntigen PresentationT Cell Activation by Dendritic CellsMHC Presentation

Varies depending on the interacting drug. Adjuvants enhance antigen presentation and DC activation. Immunosuppressants dampen DC activation and cytokine production. Checkpoint inhibitors block inhibitory signals that limit T cell activation following antigen presentation. Therapeutic vaccines deliver antigens to DCs to stimulate antigen-specific T cell responses.